P. Carrete,F. Augustovski,N. Gimpel,S. Fernandez,R. Di Paolo,I. Schaffer and F. Rubinstein. Validation of a telephone-administered geriatric depression scale in a hispanic elderly population. J Gen Intern Med. 2001;16(7):10.1046/j.1525-1497.2001.016007446.x.
M. Gerde,E. Ibarra,R. Mac Kenzie,C. Fernandez Suarez,C. Heer,R. Alvarez,M. Iglesias,J. Balparda,E. Beruti and F. Rubinstein. The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome. Thrombosis Research. 2021;206:10.1016/j.thromres.2021.08.004.
F. Piñero,F. Rubinstein,S. Marciano,N. Fernández,J. Silva,Y. Zambelo,M. Anders,A. Zerega,E. Ridruejo,C. Miguez,B. Ameigeiras,C. D’Amico,L. Gaite,C. Bermúdez,C. Rosales,G. Romero,L. McCormack,V. Reggiardo,L. Colombato,A. Gadano and M. Silva. Surveillance for Hepatocellular Carcinoma: Does the Place Where Ultrasound Is Performed Impact Its Effectiveness? Dig Dis Sci. 2019;64(3):10.1007/s10620-018-5390-z.
C. Costentin,F. Piñero,H. Degroote,A. Notarpaolo,I. F. Boin,K. Boudjema,C. Baccaro,L. G. Podestá,P. Bachellier,G. M. Ettorre,J. Poniachik,F. Muscari,F. Dibenedetto,S. H. Duque,E. Salame,U. Cillo,S. Marciano,C. Vanlemmens,S. Fagiuoli,P. Burra,H. Van Vlierberghe,D. Cherqui,Q. Lai,M. Silva,F. Rubinstein and C. Duvoux. R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation. JHEP Rep. 2022;4(5):10.1016/j.jhepr.2022.100445.
M. Mendizabal,P. Testa,M. Rojas,C. S. Colaci,S. Elías,P. Nicolini,S. Olguín,C. Dunn,C. Ronchi,M. Barreiro,M. Zirpoli,F. Piñero,S. Arora,O. F. M,F. Rubinstein and M. O. Silva. Pilot study using the ECHO model to enhance linkage to care for patients with hepatitis C in the custodial setting. J Viral Hepat. 2020;27(12):10.1111/jvh.13374.
S. J. Iribarren,H. Milligan,C. Chirico,K. Goodwin,R. Schnall,H. Telles,A. Iannizzotto,M. Sanjurjo,B. R. Lutz,K. Pike,F. Rubinstein,M. Rhodehamel,D. Leon,J. Keyes and G. Demiris. Patient-centered mobile tuberculosis treatment support tools (TB-TSTs) to improve treatment adherence: A pilot randomized controlled trial exploring feasibility, acceptability and refinement needs. Lancet Reg Health Am. 2022;13:10.1016/j.lana.2022.100291.
S. Iribarren,H. Milligan,K. Goodwin,O. A. Aguilar Vidrio,C. Chirico,H. Telles,D. Morelli,B. Lutz,J. Sprecher and F. Rubinstein. Mobile Tuberculosis Treatment Support Tools to Increase Treatment Success in Patients with Tuberculosis in Argentina: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2021;10(6):10.2196/28094.
S. J. Iribarren,S. L. Beck,P. F. Pearce,C. Chirico,M. Etchevarria and F. Rubinstein. MHEALTH INTERVENTION DEVELOPMENT TO SUPPORT PATIENTS WITH ACTIVE TUBERCULOSIS. J Mob Technol Med. 2014;3(2):10.7309/jmtm.3.2.4.
mHealth intervention development to support patients with active tuberculosis Ver más »
M. Mendizabal,V. Tagliafichi,F. Rubinstein,P. Rojas,S. Marciano,S. Yantorno,N. Cejas,M. Barrabino,M. Anders,F. Cairo,F. Villamil,L. Blazquez,A. Zerega,S. Ferretti,D. Fernández,S. Paredes,G. Aballay Soteras,L. Gaite,L. Bisigniano and M. O. Silva. Liver transplantation in adults with acute liver failure: Outcomes from the Argentinean Transplant Registry. Ann Hepatol. 2019;18(2):10.1016/j.aohep.2018.11.003.
F. Piñero,M. Anders,I. F. Boin,A. Chagas,E. Quiñonez,S. Marciano,M. Vilatobá,L. Santos,S. Hoyos Duque,A. S. Lima,J. Menendez,M. Padilla,J. Poniachik,R. Zapata,A. Soza,M. Maraschio,R. Chong Menéndez,L. Muñoz,D. Arufe,R. Figueroa,E. C. de Ataide,C. Maccali,R. Vergara Sandoval,C. Bermudez,L. G. Podesta,L. McCormack,A. Varón,A. Gadano,J. Mattera,F. Villamil,F. Rubinstein,F. Carrilho and M. Silva. Liver transplantation for hepatocellular carcinoma: impact of expansion criteria in a
